Literature DB >> 17445303

Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches.

Sean C Hinton1, Jane S Paulsen, Raymond G Hoffmann, Norman C Reynolds, Janice L Zimbelman, Stephen M Rao.   

Abstract

Huntington's disease (HD) is a neurodegenerative disorder diagnosed clinically with the development of choreiform movements. However, neuropsychological studies have demonstrated cognitive and psychiatric changes during the preclinical phase (pre-HD) prior to formal diagnosis. Previous studies have demonstrated the sensitivity of time reproduction tasks to basal ganglia pathology, as seen in clinical HD and Parkinson's disease. In this study, 29 pre-HD participants, ranging from 3 to 39 years from estimated onset (YEO) of HD based on genetic testing and chronological age, were administered the paced finger-tapping task using target intervals of 600 and 1200 ms. Mean inter-response interval, a measure of timing accuracy, did not systematically deviate from the target interval as a function of YEO. In contrast, timing variability increased curvilinearly as a function of YEO, but not with chronological age alone. Motor timing variability, but not accuracy, may serve as a marker to define the earliest behavioral changes in HD. The present study is among the first to examine the relationship between behavioral measures and YEO in pre-HD.

Entities:  

Mesh:

Year:  2007        PMID: 17445303     DOI: 10.1017/S1355617707070671

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  41 in total

1.  Time perception impairment in early-to-moderate stages of Huntington's disease is related to memory deficits.

Authors:  Stefania Righi; Luca Galli; Marco Paganini; Elisabetta Bertini; Maria Pia Viggiano; Silvia Piacentini
Journal:  Neurol Sci       Date:  2015-08-23       Impact factor: 3.307

2.  Variability in interval production is due to timing-dependent deficits in Huntington's disease.

Authors:  Ashwini K Rao; Karen S Marder; Jasim Uddin; Brian C Rakitin
Journal:  Mov Disord       Date:  2014-08-22       Impact factor: 10.338

3.  Central and peripheral timing variability in children with heavy prenatal alcohol exposure.

Authors:  Roger W Simmons; Susan S Levy; Edward P Riley; Naju M Madra; Sarah N Mattson
Journal:  Alcohol Clin Exp Res       Date:  2008-11-11       Impact factor: 3.455

4.  Early Detection of Huntington Disease.

Authors:  Jane S Paulsen
Journal:  Future Neurol       Date:  2010-01

5.  Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.

Authors:  M A Hickey; A Kosmalska; J Enayati; R Cohen; S Zeitlin; M S Levine; M-F Chesselet
Journal:  Neuroscience       Date:  2008-08-27       Impact factor: 3.590

6.  Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.

Authors:  Sarumani Natarajan Suganya; Thangarajan Sumathi
Journal:  Metab Brain Dis       Date:  2016-12-08       Impact factor: 3.584

Review 7.  Timing behavior in genetic murine models of neurological and psychiatric diseases.

Authors:  Ayşe Karson; Fuat Balcı
Journal:  Exp Brain Res       Date:  2021-01-06       Impact factor: 1.972

8.  Movement sequencing in Huntington disease.

Authors:  Nellie Georgiou-Karistianis; Jeffrey D Long; Spencer G Lourens; Julie C Stout; James A Mills; Jane S Paulsen
Journal:  World J Biol Psychiatry       Date:  2014-03-28       Impact factor: 4.132

9.  Improvement of mitochondrial function by paliperidone attenuates quinolinic acid-induced behavioural and neurochemical alterations in rats: implications in Huntington's disease.

Authors:  Jitendriya Mishra; Anil Kumar
Journal:  Neurotox Res       Date:  2014-04-22       Impact factor: 3.911

10.  Neurocognitive signs in prodromal Huntington disease.

Authors:  Julie C Stout; Jane S Paulsen; Sarah Queller; Andrea C Solomon; Kathryn B Whitlock; J Colin Campbell; Noelle Carlozzi; Kevin Duff; Leigh J Beglinger; Douglas R Langbehn; Shannon A Johnson; Kevin M Biglan; Elizabeth H Aylward
Journal:  Neuropsychology       Date:  2011-01       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.